A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A phase 1/2 trial of SHR-A2102, Adebrelimab, SHR-8068 in non-small-cell lung cancer and small-cell lung cancer, run by Shanghai Hengrui Pharmaceutical Co., Ltd., now recruiting.
Overview
A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer is a phase 1/2 interventional study registered as NCT06589778 by Shanghai Hengrui Pharmaceutical Co., Ltd., with 124 participants planned, started 2024-09-27 and due to reach its primary completion in 2026-04-30. Interventions recorded: SHR-A2102, Adebelimab (SHR-1316), SHR-8068. Conditions listed: Non-Small Cell Lung Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
Shares SHR-A2102, SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals.
- TrialA Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Small-cell lung cancer.
- TrialA Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
Shares SHR-A2102, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Small-cell lung cancer.
- TrialA Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Shares SHR-A2102, Adebrelimab, Jiangsu Hengrui Pharmaceuticals, Small-cell lung cancer.
- TrialClinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
Shares SHR-A2102, Adebrelimab, Jiangsu Hengrui Pharmaceuticals.
- TrialPhase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects
Shares SHR-A2102, Jiangsu Hengrui Pharmaceuticals, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
Shares SHR-A2102, Adebrelimab, Jiangsu Hengrui Pharmaceuticals.
- TrialA Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Shares SHR-8068, Adebrelimab, Jiangsu Hengrui Pharmaceuticals.